GPs across England are now able to prescribe weight loss injections like Mounjaro, although strict criteria must be met in order to receive them. The aim is for these jabs to eventually be more widely accessible, but for now, priority will be given to those in most need. Concerns have been raised by pharmacy trade organizations about the potential demand for Mounjaro outweighing the current supply.

Originally licensed as a weekly injection for type 2 diabetes treatment, Mounjaro, also known as tirzepatide, is now being used for weight loss purposes. The medication helps individuals feel fuller, resulting in decreased food consumption. Clinical trials have shown that people taking Mounjaro lost about 20% of their body weight.

Patients eligible to receive Mounjaro injections from GPs at this time are those with a BMI of 40 or higher, or 37.5 for certain ethnic minorities, along with specific health conditions like type 2 diabetes, high blood pressure, and heart disease. It is crucial to note that not all local GP practices will have the drug readily available, and prescriptions may also come from other primary care services.

Individuals seeking Mounjaro should be aware that not everyone meeting the criteria will immediately receive the medication due to potential supply shortages. Additionally, certain patients, such as pregnant women or those with specific health conditions, may not be suitable candidates for Mounjaro. Monitoring and support from healthcare professionals will be essential throughout the weight loss treatment process

Read the full article from The BBC here: Read More